However, FGFR1 expression is associated with unfavorable outcomes in other tumors, including lung cancer, triple-negative breast cancer, and gastric cancer, and FGFR1 may be a useful therapeutic target in these diseases [12, 14, 15]. This evidence concerns the gene FGFR1 and lung cancer.